2023 Pediatric Brain Tumor Board

Sunday, January 1, 2023, 3:30 PM - 4:30 PM, Zoom calls and Lowder Cain Conference Room, Birmingham, AL


The care of children with brain tumors requires an integrated multidisciplinary group of physicians and ancillary health care workers to manage all aspects of their diseases and provide the best, most current therapies for these patients. The Pediatric Brain Tumor Board allows this multidisciplinary team to come together to discuss each patient (new and recurrent patients), to learn about care and management options, and to determine the best course of action.

1. Describe the pathologic features of the disease processes discussed.
2. Recognize the neurosurgical aspects of curative and symptomatic approaches to care
3. Describe the diagnostic and imaging tools to evaluate the processes discussed
4. Describe the current radiation and chemotherapy treatment options for the processes discussed
5. Apply the information discussed to the care of patients

Children's of Alabama designates this Live Activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Children’s of Alabama is accredited by the Medical Association of the State of Alabama to provide continuing medical education for physicians.

AMA PRA Category 1 Credits™ (1.00 hours)

Mitigation of Relevant Financial Relationships

Children's of Alabama adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Date	Empty Column	Title
		No activities are currently published for this month.
No upcoming dates have been setup.

This activity receives no funding from any ineligible companies.